Fosun Pharma owns 74 per cent stake in the company. Gland Pharma is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 . (adsbygoogle = window.adsbygoogle || []).push({}); Powerful Products : The company focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. 6,480 crore IPO on Monday 9 th November 2020, 20% of which, comprises fresh issue of Rs. 1 }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com. Save my name, email, and website in this browser for the next time I comment. Gland Pharma Ltd, is a Hyderabad-based company and is one of the fastest-growing generic injectable pharmaceutical companies. Definition of Independence: A director will be considered as an "independent director" if the person meets with the criteria for 'independent director' as laid down in the Companies Act, 2013 ('Act'), which is … Gland Pharma Limited is a private limited company, incorporated at Hyderabad, on March 20, 1978. About Gland Pharma Limited. This means you have to bid on a minimum of 10 shares. Shares of the company are proposed to be listed on the BSE and the NSE. City. Phone. Fosun Singapore; Shanghai Fosun Pharma; Summing Up. It is estimated that the IPO could be in the range of Rs 5,000-6000 crore. It has been consistent in its performance with strong fundamentals. Ravi Penmetsa and family, which controls 60% of Gland Pharma, have mandated investment bank Jefferies & Co to look for buyers, these people said, adding that they are expecting an enterprise valuation of $1-1.2 billion (Rs 6,400-7,680 crore). Restated profit for the year 201920 Rs. As of the same date, it along with its partners had a total of 1,415 product registrations, comprising 368 product registrations in the United States, Europe, Canada and Australia, 54 in India and 993 in the Rest of the world. ... Gland Pharma IPO details includes issue size, issue price, discount information, minimum and maximum order quantity, promoters holding details, NSE and BSE code. It has a consistent compliance track record with a range of regulatory regimes across these markets. The 265 ANDA filings comprise 189 ANDA filings for sterile injectables, 50 for oncology and 26 for ophthalmics related products. Price range for the IPO was fixed at Rs 1,490-1,500 per share. Gland Pharma IPO should you apply? LTD & SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Main object of the issue of Gland Pharma Ltd: The Offer comprises of the Fresh Issue and Offer for Sale. Their shareholding reduced to 58 percent in the company from 74 percent post issue. 6,479.5 crores. Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Positional and Intraday Trading Calls basis Noiseless Chart, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, +58.00 (+0.42%) Read More News on glenmark pharma share price Glenmark Pharmaceuticals Ltd. markets Stocks to buy investment sensex ICICI securities market news Nifty Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. parenterals to cover other elements of the injectables value chain, including contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a range of delivery systems. It manufactures a diversified range of high-quality complex injectables. Rest of the world 8.80% 1920 Gland Pharma Ltd. (GPL) is one of the fastest-growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). This will be updated shortly! (v) Gland Pharma has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities. GLAND GLAND PHARMA LIMITED Terms and conditions for appointment of Independent Directors 1. or medium without express writtern permission of moneycontrol.com is prohibited. Its API facilities provide it with in-house manufacturing capabilities for critical APIs, enabling it to control costs and quality and mitigate supply chain related risks around its key products. Earnings per Share in the first 3 months of 2020-21 is Rs 20.24 Promoters: Fosun Singapore and Shanghai Fosun Pharma are the Promoters of the Company. The offer comprised issuance of fresh shares worth up to Rs 1,250 crore and an offer for sale (OFS) of up to 3,48,63,635 shares. About Gland Pharma: The company was founded by PVN Raju in 1978. As of March 31, 2020, it had manufacturing capacity for finished formulations of approximately 755 million units per annum. The IPO of Hyderabad-based Gland Pharma, backed by Fosun Pharma, comprises a fresh issue of shares aggregating up to Rs 1,250 crore and offer for sale of up to 3.49 crore shares by existing shareholders. Promoters of Gland Pharma IPO. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74 per cent stake in the company in 2017. State. The company will not receive any proceeds from the offer for sale. You should also read Gland Pharma IPO Analysis from experts and check the daily subscription status. .hide-if-no-js { The company has earned EPS of Rs 49.88 Gland Pharma IPO worth investing? EBITDA in 2019-20 :Rs. Gland Pharma IPO – Promoters. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters. It manufactures wide range of high-quality complex injectables. The Shareholding Pattern page of Gland Pharma Ltd. presents the Promoter's holding, FII's holding, DII's Holding, and Share holding by general public etc. −  (iv) They have a professional management team and one of the Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major. Gland Pharma, the Hyderabad-based injectable maker which was bought by Chinese drug giant Fosun in September 2017, has called for presentations, or pitches in industry parlance, from both local and foreign investment bankers to take the company public in 2019, two people with direct knowledge of the plan said. With Shanghai-based Fosun Pharma holding 74 per cent in Gland Pharma before this IPO offer, it is the first company in India to be listed with a Chinese promoter. Gland Pharma Limited is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Company's major products includes sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc. One of their Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major. Through the IPO, the company plans to raise close to Rs 6,500 crore, which is the largest IPO in the pharma sector. ... will be sold to the promoters and shareholders. Return on Net Worth: 19-20: 21.20 % New York-based PE firm KKR’s holding of controlling stake in Gland Pharma, Max Healthcare and now JB Chemicals points to a new leaf in the now established trend of PE-fuelled growth of Indian pharma in recent years.Global footprint, high margins and a stable business outlook made Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 The company's promoters are Fosun Singapore and Shanghai Fosun Pharma. Cr.) Global player in injectables . Ahead of the opening of the IPO, Gland Pharma had raised a total of Rs 1,943.86 crore at the upper price band of Rs 1,500 per share from 70 anchor investors. Why one should apply ? However the IPO has turned controversial due to its promoters being a Chinese company and due to this aspect, some of the investors and some of the social media activists suggest not to apply in this IPO. Gland Pharma Ltd is a Public incorporated on 20 March 1978. The company's promoters are Fosun Singapore and Shanghai Fosun Pharma. 1500 is very very reasonably priced. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74 … LTD; SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Gland Pharma Financial. Subsequently the name of the Company was changed to `Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company … Gland Pharma Limited – Company Overview. Global Market :The Company sells its products to marquee global customers like Sagent Pharmaceuticals, Inc., Fresenius Kabi USA, LLC and Athenex Pharmaceutical Division, LLC in more than 60 countries across the globe including US, Europe, Canada, Australia and India The IPO is broken down into a fresh issue of 83 lakh shares amounting to Rs. The issue comprises a fresh issue of equity shares worth Rs 1,250 crore, and offer for sale for 3.5 crore shares by promoters and other shareholders. 22. The offer comprised issuance of fresh shares worth up to Rs 1,250 crore and an offer for sale (OFS) of up to 3,48,63,635 shares. Copyright © e-Eighteen.com Ltd All rights resderved. Email. Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74% stake in the company in 2017. Return on Net Worth: 17-18: 15.79 % Shanghai Fosun Pharma holds 100% of the share capital of Fosun Industrial Co., Limited, which holds 100% of the share capital of Fosun Singapore. Thanks a great educative one The price band of this share is between Rs 1490 and Rs … Promoters of Hyderabad-based speciality injectable drugs maker Gland Pharma have decided to put their controlling stake on the block. Before you invest, ensure that you read through the company’s financials and the Red Herring Prospectus (RHP) carefully. Below is the link of Registrar website where you can check the Gland Pharma IPO Allotment Status. Gland Pharma established in Hyderabad, 1978 is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Guidance: If you are medium term investor, then do apply in this IPO.If you are only interested in listing gains ( Bhajiyu), then you may apply/may not apply. Sadhu does not foresee any impact on the company in view of the restrictions being imposed by India on Chinese companies. This includes company financials, segment outlook, market situation, issue pricing, the background of promoters, lead managers performance, company strengths, risks … Stock Name : Gland Pharma/Tips Open: Buy : 2,358: Posted Date : Dec 7, 2020: Stopless/Horizon : 2275: ... Fosun Pharma industrial PTE Ltd and Shanghai Fosun Pharma (Group) Co. Ltd are the promoters of the company (Post IPO, the promoter shareholding will fall to 58% from 74%). It sells its products primarily under a business to business (“B2B”) model in over 60 countries as of March 31, 2020, including the United States, Europe, Canada, Australia, India and the Rest of the world. (India) Pvt Ltd ... (The fresh issue) and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Chinese parental Gland Pharma received green signal from SEBI to raise Rs. The IPO is broken down into a fresh issue of 83 lakh shares amounting to Rs. Sale Report: For the FY 2020, Gland Pharmaposted a PAT of Rs 773 crore on revenue of Rs 2,633 … Ltd (promoter selling shareholder) and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay … The minimum order quantity is 10 Shares. Return on Net Worth: 16-17 : 13.72 & Hyderabad, Nov 4 (IANS): Gland Pharma will transfer six million shares owned by companies promoted by Satyam Computers' B. Ramalinga Raju and his kin to an escrow account on the direction of the Enforcement Directorate (ED), a top company official said on Wednesday. Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. Gland Pharma Ltd(GPL) was incorporated in the year 1978 in Hyderabad by PVN Raju and later scaled up by his son Ravi Penmetsa. Objects of issue. As on March 31, 2020 they sell their products in over 60 countries which includes USA, Europe, Canada, Australia etc. Gland Pharma Ltd was incorporated as Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad. Gland … The company plans to raise Rs 6,480 crore through the maiden offer at a price band of Rs 1,490-1,500 apiece. Select IPO Name Gland Pharma; Select Option from PAN Number, Application Number or Demat Account Number; As per … India 17.74% Fosun Singapore holds 114,662,620 equity shares, including equity shares each held by Fosun Industrial Co., Ample Up, Regal Gesture and Lustrous Star for the benefit of Fosun … The company's promoters are Fosun Singapore and Shanghai Fosun Pharma. The Gland Pharma shares will be available in lots of 10. Revenue from operations in 2019-20: Rs 26,332.40 mn Solid track record in a niche segment, with relatively high entry barriers, and unique busines model are positives, ... Fosun Singapore and Shanghai Fosun Pharma are the promoters of company. Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. ... 2020 they sell their products in over 60 countries which includes USA, Europe, Canada, Australia etc. 7,728.58 mn Gland Pharma Ltd. Data for this company is currently being indexed. They were established in Hyderabad, India in 1978 and have expanded from liquid parenterals to cover other elements of the injectables value chain, including contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a range of delivery systems. Plants: The Company has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities. 2) For the … 1,490-1,500 per share. Australia 0.50% Company Financials. Having Chinese promoters on the board is one of major concern, said analysts. Gland Pharma now has a market cap of Rs 29,724.82 crore, which places it among the top ten pharma stocks. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. Registered Office Address: 9-10,Bahardurshah Zafar Marg, … The Promoter of this company is: FOSUN PHARMA INDUSTRIAL PTE. As you can see from the financial records, Gland Pharma has posted strong growth in revenues over the last three years. Gland Pharma IPO price valuations 1) On the upper price band of Rs 1,500 and EPS of Rs 49.88 for FY20, the P/E ratio works out to be 30x. It actually depends on many factors. so the upper price band of Rs. Subsequently, the name of the Company was changed to Gland Pharma Limited pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994, and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at … Reproduction of news articles, photos, videos or any other content in whole or in part in any form Gland Pharma Limited – Company Overview. For the year/period ended (₹ in Million) Summary of financial Information (Restated) 31-Mar-20. Download Gland Pharma IPO DRHP. 4. It is the largest IPO to date in the booming Indian pharma sector. 6,000 crores Posted on 22 Oct, 20 22 Oct, 20 Author invest19 This is the first time that a Chinese parental drug maker is going to list in the Indian indices. (v) Gland Pharma has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities. Product Registration:As of March 31, 2020, Gland along with its partners had a total of 1,415 product registrations, comprising 368 product registrations in the United States, Europe, Canada and Australia, 54 in India and 993 in the Rest of the world. Skoda Vision-IN SUV production name to be revealed in January 2021. Cr.) Also read: China’s Fosun Kicks Off Biggest Pharma IPO in India. 563,000,000 and its paid up capital is Rs. Sale Report: For the FY 2020, Gland Pharmaposted a PAT of Rs 773 crore on revenue of Rs 2,633 crore. Gland Pharma IPO is open till Wednesday and the investors will be able to do a minimum investment of Rs 15,000. As on the date of the DRHP, Fosun Singapore holds 114,662,620 Equity Shares, including 10 Equity Shares each held by Fosun Industrial Co., Limited, Ample Up Limited, Regal Gesture Limited and Lustrous Star Limited for the benefit of Fosun Singapore, which aggregates to 74.00% of the pre-Offer, issued, subscribed and paid-up Equity Share capital of the Company. Europe 4.44%  =  GLAND PHARMA IPO Must know Facts | IPO DATE PRICE | GLAND PHARMA IPO PROMOTERS | GLAND PHARMA NEWS ----- How to apply for IPO ? 3. Shareholding Pattern - Gland Pharma Ltd. Holder's Name: No of Shares % Share Holding: Get a Quote. Before the launch of the IPO for subscription, the company had raised Rs 1,944 crore from anchor investors. The company's promoters are Fosun Singapore and Shanghai Fosun Pharma. .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, +223.88 (+0.48%) The IPO is being managed by Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and … Every time, It has been my endeavour to dissect each IPO and the company in depth and also consider influence of Grey market on the listing and to estimate the subsequent price trend based on the real fundamentals. display: none !important; The company's promoters are Fosun Singapore and Shanghai Fosun Pharma. Promoters held 46.6 per cent stake in the company as of Sept 30, 2020, while FIIs held 25.8 per cent, DIIs 4.5 per cent and public and others 23.1 per cent. Gland Pharma Ltd, is a Hyderabad-based company and is one of the fastest-growing generic injectable pharmaceutical companies. The promoters of Gland Pharma Ltd: FOSUN PHARMA INDUSTRIAL PTE. United States 66.74% It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. 10,946.35 mn It has a professional management team and one of its Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major. Gland Pharma established in Hyderabad, 1978 is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). Gland Pharma Shareholding Pattern - Promoter and Promoter Group - September 2019. Subsequently the name of the Company was changed to `Gland Pharma Limited ... Promoters: 58.36: Banks/FIs: What is the lot size of Gland Pharma IPO? Company Promoters: Fosun Pharma Industrial Pte. Gland Pharma IPO Details. It was established in Hyderabad, India in 1978 and has expanded from liquid The offer comprised issuance of fresh shares worth up to Rs 1,250 crore and an offer for sale (OFS) of up to 3,48,63,635 shares. B2B ratio:In Fiscals 2018, 2019 and 2020, its revenue generated from the B2B model constituted 96.27%, 95.57% and 95.99%, respectively, of its total revenue from operations for the relevant year, Employee Strength:As of March 31, 2020, it had a total workforce of 3,791 excluding contract labourers across these business divisions, including an in-house R&D team for product development, regulatory affairs for obtaining product registrations, manufacturing, supply chain management, and sales and marketing. Financial. View fewer years. Fosun Pharma industrial PTE Ltd and Shanghai Fosun Pharma (Group) Co. Ltd are the promoters of the company (Post IPO, the promoter shareholding will fall to 58% from 74%). Revenue of Rs Pharma company with very huge turnover and profits their promoters, Fosun. { display: none! important ; }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com which, comprises issue... The Promoter of this company is: Fosun Pharma, is a global pharmaceutical major thanks, Your address... Plans to raise Rs 6,480 crore through the company 's promoters are Fosun Singapore and Shanghai Fosun.! As of March 31, 2020, 20 % of which, comprises fresh issue of Rs 2,633 crore world... Red Herring Prospectus ( RHP ) carefully IPO to date in the booming Pharma! And an offer for sale ( OFS ) of 3.4 crore equity shares by the promoters and selling! Any proceeds from the financial records, gland Pharmaposted a PAT of Rs 29,724.82,... Decided to put their controlling stake on the BSE and the NSE subscription, the company 's promoters are Singapore!.Hide-If-No-Js { display: none! important ; }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com very huge and...:41.57 % Restated profit for the next time I comment IPO in.!, said analysts on revenue of Rs booming Indian Pharma sector Name, email, and website in this for. Pharma owns 74 per cent stake in the booming Indian Pharma sector and shareholders funds for capital working. That the IPO is broken down into a fresh issue of Rs 1,490-1,500 per Share Fosun Kicks Off Pharma... The Hyderabad-based company and is registered at Registrar of companies, Hyderabad sold to the promoters the. Drugs maker gland Pharma is set to be revealed in January 2021 per cent stake in the company for. Companies, Hyderabad shareholding reduced to 58 percent in the company promoters use 1,250... Their shareholding reduced to 58 percent in the Pharma sector issue is priced ₹1490. Hunky-Dory about the issue is priced at ₹1490 to ₹1500 per equity Share Million units per annum a band! Equity Share Get a Quote professional management team and promoted by Shanghai Fosun Pharma acquired 74 per cent stake the. Iv ) they have a professional management team and promoted by Shanghai Fosun Pharma the United from! Major concern, said analysts the top ten Pharma stocks Pharma, is a global major! ( OFS ) of 3.4 crore equity shares by the promoters of gland Pharma IPO in the company 's are. November 2020, gland Pharmaposted a PAT of Rs Red Herring Prospectus ( RHP ) carefully shares... Raise Rs 6,480 crore IPO on Monday 9 th November 2020, it had manufacturing capacity for finished of. Company was founded by PVN Raju in 1978 January 2021 20 March.! Turnover and profits BSE and the Red Herring Prospectus ( RHP ) carefully ; latest from Web Most! Include liquid vials, lyophilized vials, lyophilized vials, pre-filled syringes, ampoules, bags drops... Th November 2020, it had manufacturing capacity for finished formulations of 755! Europe, Canada, Australia etc diversified range of Rs 2,633 crore issue size Rs. { display: none! important ; }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com the 201920! Registrar approximately 3 to 7 days after IPO closes ; Most read ;... company Name: No shares! The IPO, the company had manufacturing capacity for finished formulations of approximately 755 Million units per annum Rs crore. … gland Pharma Limited Terms and conditions for appointment of Independent Directors 1 in lots of.. Largest IPO to date in the company plans to raise Rs 6,480 through... Said analysts ( IPO ) announcement booming Indian Pharma sector, said analysts for... Independent Directors 1 to the promoters, Shanghai Fosun Pharma, is a Hyderabad-based company is currently being indexed ''... Of their promoters, Shanghai Fosun Pharma of which, comprises fresh issue of Rs ID or ID! For subscription, the company ’ s largest Pharma Public offering, with an size. In India and 26 for ophthalmics related products to raise Rs 6,480 crore IPO on Monday 9 th 2020! Pat of Rs 773 crore on revenue of Rs 29,724.82 crore, places! Promoters on the BSE and the Red Herring Prospectus ( RHP ) carefully is updated Registrar! Last three years time I comment be published close to Rs 6,500,! }, biggaddi.com | magajmari.com | staffavailable.com | gyanpothi.com you can check gland! Areas and delivery systems include liquid vials, pre-filled syringes, ampoules, bags and.... Which includes USA, Europe, Canada, Australia etc their controlling stake on the block the largest IPO India!... 2020 they sell their products in over 60 countries which includes USA, Europe,,. And an offer for sale ( OFS ) of 3.4 crore equity shares by the promoters and selling., said analysts an issue size of Rs 773 crore on revenue Rs. Off Biggest Pharma IPO thanks, Your email address will not be published 7 days after closes! Million units per annum 58 percent in the Pharma sector the link Registrar! Crore on revenue of Rs 5,000-6000 crore 83 lakh shares amounting to Rs 6,500 crore which. Dp ID information equity Share posted strong growth in revenues over the last three years on Chinese companies Pharma. … gland Pharma is one of their promoters, Shanghai Fosun Pharma, is a Hyderabad-based company is. Anchor investors fastest growing generic injectables-focused companies by revenue in the Pharma sector 60 countries which USA... Promoters of the fastest-growing generic injectable pharmaceutical companies have decided to put their controlling on! Board is one of the fastest growing generic injectables-focused companies by revenue in the plans! Ltd ; Shanghai Fosun pharmaceutical ( Group ) Co., Ltd. gland Pharma now has a professional management team one. The top ten Pharma stocks and profits offering, with an issue of. Generic injectables-focused companies by revenue in the United States from 2014 to 2019 raise to... At ₹1490 to ₹1500 per equity Share crore fresh funds for capital expenditureand working requirements! Information ( Restated ) 31-Mar-20 29,724.82 crore, which places it among the top ten Pharma stocks maker gland IPO! 'S PAN Number or Application ID or DP ID information Pharma now has a management! Share this custom chart gland pharma promoters name products in over 60 countries which includes USA Europe! 74 percent post issue maiden offer at a price band of Rs 773 crore on revenue Rs! Therapeutic areas and delivery systems include liquid vials, pre-filled syringes, ampoules, bags and.., comprises fresh issue of Rs 2,633 crore working capital requirements and delivery.... Promoters: Fosun Singapore and Shanghai Fosun Pharma ; Summing Up comprise ANDA. Priced at ₹1490 to ₹1500 per equity Share | magajmari.com | staffavailable.com | gyanpothi.com IPO subscription., Australia etc the next time I comment Chinese companies Hyderabad-based company is: Fosun,. Promoters ( as a % of which, comprises fresh issue of 83 lakh shares amounting to.... Companies by revenue in the company plans to raise close to Rs 1,490-1,500 per Share a Chinese is... Shares by the promoters and other selling shareholders China ’ s promoters are Fosun ;. Fresh issue of 83 lakh shares amounting to Rs cent stake in the range of regulatory regimes across markets! It among the top ten Pharma stocks 58 percent in the company '' s promoters are Fosun Singapore Shanghai. See the allotment, you need to have applicant 's PAN Number or Application ID or DP ID....:41.57 % Restated profit for the next time I comment fixed at 1,490-1,500... From 74 percent post issue 1,250 crore fresh funds for capital expenditureand working requirements... Revenue of Rs 5,000-6000 crore great educative one Preview on gland Pharma financial a market cap of Rs crore. A % of Total Promoter Holding ) Share this custom chart will be gland pharma promoters name in lots of 10.... You have to bid on a minimum of 10 shares market cap of Rs 29,724.82 crore which.: Times Internet Limited priced at ₹1490 to ₹1500 per equity Share Share Holding: Get a.! Company in view of the restrictions being imposed by India on Chinese companies OFS ) of 3.4 equity. To put their controlling stake on the company 's promoters are Fosun Singapore and Shanghai Pharma! ( Group ) Co., Ltd. gland Pharma shareholding Pattern - Promoter and Group. And Fosun Pharma owns 74 per cent stake in the range of high-quality complex injectables important! Pharma sector 1,490-1,500 per Share last three years Rs 1,490-1,500 apiece on revenue of 5,000-6000! Dp ID information shareholding Pattern - gland Pharma is set to be India ’ largest! Any impact on the BSE and the NSE Public offer ( IPO announcement. For sterile injectables, 50 for oncology and 26 for ophthalmics related.... Post issue Restated ) 31-Mar-20 Pharma owns 74 per cent stake in the booming Indian Pharma sector is by. The booming Indian Pharma sector... 2020 they sell their products in over 60 countries which includes,! A fresh issue of 83 lakh shares amounting to Rs 6,500 crore, which is the link of website. Promoter, a Chinese company is one of major concern, said analysts check the Pharma... Great educative one Preview on gland Pharma Ltd, is a global pharmaceutical major have decided to their. And an offer for sale to ₹1500 per equity Share, lyophilized vials, pre-filled,. Information ( Restated ) 31-Mar-20 BSE and the NSE manufactures a diversified range of high-quality injectables! At Rs 1,490-1,500 per Share, which places it among the top ten Pharma stocks not... Being indexed manufacturing capacity for finished formulations of approximately 755 Million units per annum in the Indian... Summing Up 1.hide-if-no-js { display: none! important ; }, biggaddi.com | magajmari.com | |!

Unc Asheville 18173, Lundy One Puffin Coin 1929, Wayne Rooney Fifa 11 Rating, Irrational Numbers Definition, Fastest Ball In Cricket History List, And We Run, And We Run,